Blistex ® Maximum Hydration Lip Ointment

Manufacturer
Blistex Inc.
Effective date
2026-05-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
weekly-update
Hydrated at
2026-07-17 21:41:55

Label at a glance#

ProductBlistex Maximum Hydration Lip
Active ingredientCAMPHOR (SYNTHETIC), DIMETHICONE, UNSPECIFIED, MENTHOL, UNSPECIFIED FORM, PHENOL
Label structure7 sections

Indications and uses

for the temporary relief of pain and itching associated with minor lip irritation or cold sores temporarily protects and helps relieve chapped or cracked lips

Dosage and administration

adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily children under 2 years of age: Consult a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientsPurpose
Camphor 0.5% (w/w)External analgesic
Dimethicone 1.1% (w/w)Lip protectant
Menthol 0.625% (w/w)External analgesic
Phenol 0.5% (w/w)External analgesic

Uses

INDICATIONS & USAGE SECTION

  • for the temporary relief of pain and itching associated with minor lip irritation or cold sores
  • temporarily protects and helps relieve chapped or cracked lips

Warnings

WARNINGS SECTION

For external use only

Do not use on

OTC - DO NOT USE SECTION

  • deep or puncture wounds
  • animal bites
  • serious burns

When using this product

OTC - WHEN USING SECTION

  • do not get into eyes
  • do not apply over large areas of the body or bandage

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily
  • children under 2 years of age: Consult a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

allantoin, ammonium hydroxide, beeswax, calcium disodium EDTA, calcium hydroxide, cetyl alcohol, flavors, glycerin, hydrated silica, lanolin, lauric acid, mineral oil, myristic acid, oleic acid, palmitic acid, paraffin, petrolatum, polyglyceryl-3 diisostearate, potassium hydroxide, purified water, SD alcohol 36, sodium hydroxide, sodium saccharin, stearyl alcohol

PRINCIPAL DISPLAY PANEL - 7 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NEW
LARGER
SIZE

Blistex®
DERMATOLOGIST RECOMMENDED

MAXIMUM
HYDRATION
LIP OINTMENT

LIP PROTECTANT/EXTERNAL ANALGESIC

+
24HR
MOISTURE

Medicated Formula Provides
Maximum Moisture for Severe Lip Dryness

Net Wt. 0.25 oz. (7 g) Ea.

Principal Display Panel - 7 g Tube Carton
Principal Display Panel - 7 g Tube Carton

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130041388014012GTIN-13: 0041388014012
EAN-13: 0041388014012
GTIN-12: 041388014012
UPC-A: 041388014012
GTIN storage (14 digits): 00041388014012
maximum-hydration-01.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10157-991310157-9913-1, 10157-9913-2, 10157-9913-3, 10157-9913-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Blistex Maximum Hydration LipCAMPHOR (SYNTHETIC), DIMETHICONE, UNSPECIFIED, MENTHOL, UNSPECIFIED FORM, AND PHENOLBlistex Inc.fed223bc-edf3-46eb-b678-acb906f9ef112026-05-18WarningsExact identifier
ndc (package): 10157-9913-2
ndc (package): 10157-9913-1
ndc (package): 10157-9913-3
ndc (package): 10157-9913-4
ndc (product): 10157-9913
ndc11 (package): 10157991302
ndc11 (package): 10157991304
ndc11 (package): 10157991303
ndc11 (package): 10157991301
spl id: a52e5b7f-f4fd-44ac-80bf-e07140ce49e5
spl set id: fed223bc-edf3-46eb-b678-acb906f9ef11

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.